Monday, November 9, 2026

Texas Instruments And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Texas Instruments  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Texas Instruments (TXN), Adobe (ADBE), Monmouth Real Estate Investment Corporation (MNR) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Texas Instruments (TXN)

33.5% sales growth and 68.98% return on equity

Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers worldwide.

Texas Instruments's sales growth this year is expected to be 21.1% and 4% for next year.

Year-on-year quarterly revenue growth grew by 28.8%, now sitting on 15.42B for the twelve trailing months.

Volume

Today's last reported volume for Texas Instruments is 2758440 which is 33.41% below its average volume of 4142690.

Texas Instruments's sales growth for the next quarter is 33.5%. The company's growth estimates for the current quarter and the next is 23% and 35.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 68.98%.

Volatility

Texas Instruments's last day, last week, and last month's current volatility was 0.82%, 0.72%, and 0.80%, respectively.

Texas Instruments's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.12% (day), 1.64% (last week), and 1.48% (last month), respectively.

Texas Instruments's Stock Yearly Top and Bottom Value

Texas Instruments's stock is valued at $190.27 at 02:22 EST, under its 52-week high of $197.58 and way above its 52-week low of $125.43.

Texas Instruments's Moving Average

Texas Instruments's worth is higher than its 50-day moving average of $188.59 and above its 200-day moving average of $179.90.

Previous days news about Texas Instruments(TXN)

According to Business Insider on Monday, 5 July, "What's next: Dantsoho will be doing a firmware engineering internship at Texas Instruments this summer before starting a master's program in computer engineering at Columbia University in the fall."

2. Adobe (ADBE)

18.1% sales growth and 45.14% return on equity

Adobe Inc. operates as a diversified software company worldwide.

Adobe's sales growth this year is anticipated to be 21.9% and 14.9% for next year.

Year-on-year quarterly revenue growth grew by 22.6%, now sitting on 14.39B for the twelve trailing months.

Volume

Today's last reported volume for Adobe is 2099790 which is 0.8% above its average volume of 2083070.

Adobe's sales growth is a negative 0% for the ongoing quarter and 18.1% for the next. The company's growth estimates for the current quarter and the next is 17.1% and 9.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 45.14%.

Volatility

Adobe's last day, last week, and last month's current volatility was 0.24%, 0.77%, and 1.16%, respectively.

Adobe's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.42% (day), 1.58% (last week), and 1.90% (last month), respectively.

Adobe's Stock Yearly Top and Bottom Value

Adobe's stock is valued at $604.50 at 02:22 EST, under its 52-week high of $607.67 and way above its 52-week low of $416.29.

Adobe's Moving Average

Adobe's value is way above its 50-day moving average of $541.77 and way higher than its 200-day moving average of $495.34.

Previous days news about Adobe(ADBE)

According to Zacks Investment Research on Thursday, 8 July, "Investors re-entered tech stocks back in mid-May, as the Nasdaq and market-movers from Apple (AAPL Quick QuoteAAPL - Free Report) to Adobe ADBE reached attractive entry points."

3. Monmouth Real Estate Investment Corporation (MNR)

14.5% sales growth and 9.77% return on equity

Monmouth Real Estate Investment Corporation, founded in 1968, is one of the oldest public equity REITs in the world.

Monmouth Real Estate Investment Corporation's sales growth this year is expected to be 10.3% and 6.1% for next year.

Year-on-year quarterly revenue growth grew by 11.2%, now sitting on 174.36M for the twelve trailing months.

Volume

Today's last reported volume for Monmouth Real Estate Investment Corporation is 488378 which is 15.41% below its average volume of 577352.

Monmouth Real Estate Investment Corporation's sales growth is a negative 0% for the ongoing quarter and 14.5% for the next. The company's growth estimates for the current quarter and the next is a negative 74.1% and 366.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.77%.

Volatility

Monmouth Real Estate Investment Corporation's last day, last week, and last month's current volatility was 1.48%, 0.56%, and 0.98%, respectively.

Monmouth Real Estate Investment Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.86% (day), 1.26% (last week), and 1.75% (last month), respectively.

Monmouth Real Estate Investment Corporation's Stock Yearly Top and Bottom Value

Monmouth Real Estate Investment Corporation's stock is valued at $18.72 at 02:22 EST, below its 52-week high of $19.76 and way above its 52-week low of $13.01.

Monmouth Real Estate Investment Corporation's Moving Average

Monmouth Real Estate Investment Corporation's value is below its 50-day moving average of $19.08 and higher than its 200-day moving average of $18.20.

4. Broadcom (AVGO)

11.6% sales growth and 20.38% return on equity

Broadcom Inc. designs, develops, and supplies a range of semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide.

Broadcom's sales growth this year is anticipated to be 14.1% and 5.7% for next year.

Year-on-year quarterly revenue growth grew by 15.1%, now sitting on 25.55B for the twelve trailing months.

Volume

Today's last reported volume for Broadcom is 1619250 which is 10.04% below its average volume of 1799910.

Broadcom's sales growth is a negative 0% for the present quarter and 11.6% for the next. The company's growth estimates for the ongoing quarter and the next is 26.9% and 17.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.38%.

Volatility

Broadcom's last day, last week, and last month's current volatility was 2.06%, 0.89%, and 0.95%, respectively.

Broadcom's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.75% (day), 2.71% (last week), and 1.99% (last month), respectively.

Broadcom's Stock Yearly Top and Bottom Value

Broadcom's stock is valued at $480.18 at 02:22 EST, below its 52-week high of $495.14 and way higher than its 52-week low of $304.18.

Broadcom's Moving Average

Broadcom's worth is above its 50-day moving average of $467.28 and above its 200-day moving average of $461.27.

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cycle: Data Readouts, FDA Decisions and Capital-Allocation Shifts
From late October to January, mid-cap biotechs move through a dense run of events: ESMO and AHA/AASLD data presentations, Q3 earnings, and FDA PDUFA dates for ivonescimab (Nov 14) and lorundrostat (Dec 22). Alongside the regulatory news, companies are changing how they allocate capital: one lowered FY2026 R&D and SG&A guidance and pushed milestones into 2027, one authorized a $400M buyback, and one scheduled a delisting vote (EGM Nov 19, application Jan 25). Value is concentrating in a few binary regulatory and Phase 3 outcomes (Maritime-1 and ECLIPSE 2/3 readouts around Q1 2027), so sentiment is mixed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,558 source documents archived
Query this data → isubstrate.com